LMEDICATION
ActiveSummary
LMEDICATION has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €44,934 and a net result of €39,690. Equity is growing by about 28% per year across the filed financial years. Its solvency ranks better than 38% of 22,382 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.2% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
29-06
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Highest result from 2022 to 2025net €39,690 ▲16.2%
Operating result €57,201, net result €39,690, both a record.
31-12
Financial
Liquidity more than triplescurrent ratio 6.34
Current ratio from 1.61 to 6.34; short-term debt falls from €82,658 to €18,102.
18-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
09-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
23-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 23 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.